Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
07/05/2026 21:05
May 07 (Reuters) - Amphastar Pharmaceuticals Q1 net income USD 6.42 million. Q1 revenue USD 171.171 million vs. IBES estimate USD 173.4 million Q1 adjusted net income USD 19.478 million vs. IBES estimate USD 33.2 million Q1 adjusted EPS USD 0.42 vs. IBES estimate USD 0.7
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing